Recruiting
Multi-Omics for Maternal Health After Preeclampsia
To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.
ClinicalTrials.gov IDNCT06340152
PhaseNot Applicable
Enrollment1100
SponsorUniversity of California, San Diego
Age18 Years
SexFEMALE
Conditions studied
Pre-Eclampsia, Pregnancy Induced Hypertension
About this study
To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.
Primary outcomes
- Preeclampsia (2nd trimester - 13 months postpartum)
- Gestational hypertension (2nd trimester - Delivery)
- Postpartum hypertension (Delivery - 13 months postpartum)
Eligibility information
Inclusion Criteria:
* Pregnant women 18 years of age to 50 years of age
* 10-24 weeks gestation at time of enrollment
* Singleton pregnancy
* Planning to deliver at a study site (UCSD or VUMC)
Exclusion Criteria:
* Inability to give informed consent
* Intrauterine fetal demise
* Fetal genetic or structural anomaly
* Institutionalization for psychiatric disorder, mental deficiency or incarcerated
* Active or history of malignancy requiring major surgery or systemic chemotherapy
* Multi-fetal gestation or a twin demise at any gestational age
* Known maternal or fetal chromosomal anomalies
* Patients who plan to keep their placenta after delivery
Study locations
- University of California, San Diego, San Diego, California 92037 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.